CCCC icon

C4 Therapeutics
CCCC

Overview Fund Trends Analyst Outlook Journalist POV

75 hedge funds and large institutions have $743M invested in C4 Therapeutics in 2020 Q4 according to their latest regulatory filings, with 75 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
75
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$105M
2
+$80M
3
+$68.7M
4
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
+$54.4M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$49.4M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$5.43M
27
$5.02M
28
$4.75M
29
$4.62M
30
$4.14M
31
$3.65M
32
$3.64M
33
$3.63M
34
$3.44M
35
$3.34M
36
$2.21M
37
$1.32M
38
$1.32M
39
$1.32M
40
$1.28M
41
$939K
42
$816K
43
$707K
44
$663K
45
$663K
46
$663K
47
$663K
48
$662K
49
$537K
50
$535K
1
2
3